Amwill Healthcare SME: Check IPO Date, Live Subscription and Key Details
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development company that collaborates with contract manufacturers, distributors, and third-party product developers. These partnerships help enhance its manufacturing, packaging, and distribution capabilities.
Price Range
₹105.0 - ₹111.0
Issue Size
₹59.98 Cr
Lot Size
1,200 shares
IPO Type
BSE SME
GMP
-
Est. Listing Price
₹111
Estimate Profit
-
Retail Portion
-
Key Metrics
Check Live GMPGMPFace Value
₹10
EPS
6.52
P/E Ratio
17.04
RoNW
73.06%
ROE
73.06%
Advertisement
Timeline
IPO Opens
5 Feb
IPO Closes
7 Feb
Allotment
10 Feb
Listing
12 Feb
IPO Timeline & Listing Details
| Event | Date | Details |
|---|---|---|
| IPO Open Date | 5 February 2025 | Subscription starts |
| IPO Close Date | 7 February 2025 | Subscription ends |
| Allotment Date | 10 February 2025 | Allotment |
| Listing Date | 12 February 2025 | Listing |
Investment Categories
| Category | Lots | Amount |
|---|---|---|
Individual | 2 | ₹2,66,400 |
SHNI (Min) | 3 | ₹3,99,600 |
SHNI (Max) | 7 | ₹9,32,400 |
BHNIAbove ₹10,00,000 | 8 | ₹10,65,600 |
IPO Objectives
- Funding of working capital requirements of the Company
- Marketing and brand-building activities
- General corporate purposes
Strengths
- Wide range of dermatological products addressing various skin conditions and treatments.
- Strong collaboration with contract manufacturers ensures high-quality production.
- Skilled management team with expertise in execution and market expansion.
- Asset-light model minimizes operational costs and financial risks.
- Strategic focus on Karnataka, Andhra Pradesh, and Telangana for growth.
Weaknesses
- Limited presence restricts nationwide expansion and brand visibility.
- Relying on third-party manufacturers may affect quality control and supply consistency.
- Intense competition in the derma-cosmetic industry challenges market positioning and pricing.
- Strict regulatory requirements can delay product approvals and launches.
Advertisement
Financial Performance
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets (₹ Cr.) | 28.89 | 18.98 | 12.39 | 6.59 |
| Revenue (₹ Cr.) | 23.25 | 44.28 | 30.28 | 27.62 |
| PAT (₹ Cr.) | 6.52 | 12.54 | 3.11 | 2.57 |
| Net Worth (₹ Cr.) | 23.68 | 17.16 | 4.6 | 1.49 |
Peer Comparison
| Company | P/B Ratio | P/E Ratio | RONW (%) | Net Worth (₹ Cr.) |
|---|---|---|---|---|
| Amwill Healthcare Limited | 10.09 | 17.04 | 73.06% | 23.68 |
| Vaishali Pharma Limited | 2.78 | 169.5 | 1.68% | 42.84 |
| Trident Lifeline Ltd | 4.99 | 28.18 | 13.37% | 53.95 |
Subscription Details
Daily Bids Status
| Category | Day 1 | Day 2 | Day 3 |
|---|---|---|---|
| QIB | 2.19x | 2.19x | 7.8x |
| NII | 0.51x | 0.53x | 5.66x |
| RII | 1x | 1.92x | 4.77x |
| Total | 1.04x | 1.42x | 5.73x |
Overall Subscription Statistics
| Category | Shares Offered | Shares Bid | Bid Amount (₹ Cr) |
|---|---|---|---|
| QIB | 10,26,000 | 80,01,600 | 88.82 |
| NII | 20,53,200 | 1,16,20,800 | 128.99 |
| RII | 20,53,200 | 97,83,600 | 108.6 |
| Total | 51,32,400 | 2,94,06,000 | 326.41 |
Advertisement
Company Details
- Amwill Healthcare Limited
- No. 157, 1st Floor, 2nd Main, r, 2nd Main, 3rd Cross Chamrajpet Bangalore – 560018
- +91 8043026281
- amwill@amwillhealthcare.com
- https://www.amwillhealthcare.com/
Registrar Details
- Bigshare Services Pvt Ltd
- +91-22-6263 8200
- investor@bigshareonline.com
- https://ipo.bigshareonline.com/IPO_Status.html
Loading comments...